Fair trade regulator the Competition Commission of India (CCI) has approved the acquisition of US-based biotech major Monsanto by German chemical and pharma major Bayer. However, the approval is subject to compliance of “certain modifications,” reported Reuters.
A source with direct knowledge of the matter said the CCI’s clearance was among the last antitrust hurdles for the deal.
The CCI hasn’t yet made public the conditions imposed, but the source said the watchdog had asked for divestment of Bayer’s agriculture seeds, vegetable seeds, glufosinate-ammonium and the digital agriculture business.
In a statement on Tuesday, May 22, Bayer said the Indian clearance was “another milestone” towards the global acquisition.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Atkore Faces Shareholder Lawsuit Over Alleged Price-Fixing Scheme
Mar 19, 2025 by
CPI
US Appeals Court Upholds Ruling Denying Copyright for AI-Generated Art
Mar 19, 2025 by
CPI
Morrison Foerster Expands European Antitrust Practice
Mar 19, 2025 by
CPI
HSBC in Advanced Talks to Sell German Fund Unit to BlackFin Capital Partners
Mar 19, 2025 by
CPI
EU’s Antitrust War on Big Tech Heats Up as US Trade Disputes Grow
Mar 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li